Tilmann Bochtler
Hat mitgewirkt an:
-
Analyse der proliferierenden und ruhenden Fraktion von malignen B-Zellen bei der chronischen lymphatischen Leukämie
-
Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute...
-
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
-
Karyotype complexity and prognosis in acute myeloid leukemia